Let's get Phase III funded!

What began as a bold vision in 2015 has become a powerful reality. Phase I of the mistletoe clinical trial, the first of its kind in the United States, is now complete, thanks to Believe Big and the unwavering support of this incredible community.

The results are deeply encouraging. The trial demonstrated that mistletoe is safe, identified a recommended dosage, and showed promising potential to improve patients’ quality of life. These outcomes were strong enough to advance the research forward, an important milestone in bringing mistletoe therapy closer to standard oncology care.

But the journey isn’t over.

Phase III is the critical next step to get funded.
Let’s finish what we started.
Let’s get Phase III funded, together.

Mistletoe Clinical Trial - Phase III

Team Members